IDXX
IDEXX Laboratories, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-02-20
Figures on this page computed 2026-11-08 12:33 UTC
Last close
698.55USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2025, filed 2026-02-20
51.3xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-20
54.3%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
24.6%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
24.6%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
0.36Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Price is the furthest below its sector's middle: 0.09 against 0.36 on the market's range.
- Growth9.7%59 of 100, above its sector
- Returns on capital54.3%98 of 100, above its sector
- Margins61.8%88 of 100, above its sector
- Price51.3x9 of 100, below its sector
- Safety0.3669 of 100, above its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Against its rival
lens 4 of 9Measure by measure
behind on 1 of 4- Profit on each unit of sales24.6%20.3%Ahead
Higher is better here.
- Return on the capital it uses54.3%n/an/a
Higher is better here.
- Sales growth over five years9.7%6%Ahead
Higher is better here.
- Debt against equity0.36n/an/a
Lower is better here.
- Gross margin61.8%59.3%Ahead
Higher is better here.
- Price against earnings51.3x42.4xBehind
Lower is better here.
The first column is this company and the second is the one it is set against. A measure only one of the two reports is left at n/a rather than counted as a win.
Against Waters Corporation, IDXX is behind on 1 of 4 measures.
Against Waters Corporation, IDXX is behind on 1 of 4 measures.
Every figure in this lens
Except where said otherwise: 10-K for 2025, filed 2026-02-20
Profit on each unit of sales24.6%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
Return on the capital it uses54.3%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
Sales growth over five years9.7%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
Debt against equity0.36
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
Gross margin61.8%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
Price against earnings51.3x
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD